Lung Biotechnology Lung Biotechnology is a company using biotechnology to design therapies for pulmonary arterial hypertension and other fatal lung diseases. | Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||
Founding Date | Founding Date 2006 | Founding Date 1995 | Founding Date 1978 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Silver Spring, US HQ | Locations Austin, US HQ Hørsholm, DK | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees N/A | Employees 2827% increase | Employees 7,605 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 605.7 m | Valuation ($) 26.7 b |
Financial | |||
Net income | Net income N/A | Net income ($118.8m) (FY, 2025) | Net income $1.3b (FY, 2025) |

Savara (also known as Savara Pharmaceuticals) is an orphan lung disease company.
View companyBiogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company